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Purpose: To find the gene mutated in a large English family affected by autosomal 
dominant Retinitis Pigmentosa (adRP) with variable expressivity. 
Methods: After examination, blood samples were obtained for ten members of this 
family. Genomic DNA was isolated and markers for know adRP genes were tested. RNA 
was extracted and cDNA made for an affected individual. cDNA for PRPF8 was 
sequenced for this individual as well as direct  sequencing was performed on the DNA 
for the reminding individuals.  
Results: The disease in the family was linked to chromosome 17, at the PRPF8 locus. A 
new change 6445 C>T was found in exon 39 of PRPF8. The change segregates with the 
disease in the family. It was not found in 130 controls indicating this change is 
responsible for the disease in the family. It is interesting to note that this is the first time a 
mutation in PRPF8 is found in another exon than exon 43.  
Conclusions: A new mutation Ser 2118 Phe was reported in exon 39 of PRPF8 in a 
family affected by adRP with variable expressivity. Incomplete penetrance can be 
considered as an extreme case of variable expressivity. It can be difficult to distinguish 
between them at young age. So far, only mutations in PRPF31 have been discovered in 
adRP families with incomplete penetrance. We suggest that it will be worth screening 
PRPF8 in adRP families with incomplete penetrance and when PRPF31 mutation is 
absent.  
 
 
 
 
